Indications for palliative reduction surgery in advanced hepatocellular carcinoma: The use of a remnant tumor index

Archives of Surgery

Volumn 132, Issue 2, 1997, Pages 120-123

  Yamamoto, Kazuharu ^a   Takenaka, Kenji ^a,b   Kawahara, Naoyuki ^a   Shimada, Mitsuo ^a   Shirabe, Ken ^a   Itasaka, Hidetoshi ^a   Nishizaki, Takashi ^a   Yanaga, Katsuhiko ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER SURGERY; MALE; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0031039490     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430260018002     Document Type: Article

References (19)

1. Heiken JP, Weyman DJ, Lee JKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portgraphy, and MR imaging. Radiology. 1989;172:27-34.
2. Honda H, Ochiai K, Adachi E, et al. Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings. Radiology. 1993;189:857-862.
3. Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T, Sugimachi K. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma Br J Surg. 1990;77:677-680.
4. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-2780.
5. Pelletier G, Roche A, Ink O, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 1990;11:181-184.
6. Nishimine K, Uchida H, Matsuo N, et al. Segmental transarterial chemoembolization with lipiodol mixed anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol. 1994;33(suppl):S60-S68.
7. Lygidakis NJ, Savanis G, Konstantinidou AE, et al. A new look in the management of unresectable primary hepatocellular carcinoma. Hepatogastroenterology. 1992;39:577-583.
8. Hamazoe R, Hirooka Y, Ohtani S, Katoh T, Kaibara N. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer. 1994;75:794-800.
9. Koda M, Okamoto K, Miyoshi Y, et al. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma. Hepatogastroenterology. 1994;41:25-29.
10. Yamamoto M, Iizuka H, Fujii H, Matsuda M, Miura K. Hepatic arterial Infusion of interleukin-2 in advanced hepatocellular carcinoma. Acta Oncol. 1993;32: 43-51.
11. Ito K, Kusunoki H, Okamoto E, et al. Intra-arterial alcoholization of advanced hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33(suppl):S42-S47.
12. Chen SC, Lian SL, Chang WY. The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33(suppl):S124-S127.
13. Yamamoto M, Iizuka H, Matsuda M, Nagahori K, Miura K, Itakura J. The indications for tumor mass reduction surgery and subsequent multidisciplinary treatment in stage IV hepatocellular carcinoma. Surg Today. 1993;23:675-81.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
15. Urata K, Matsumata T, Kamakura T, Hasuo K, Sugimachi K. Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis. J Surg Oncol. 1994;56:54-58.
16. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256-1261.
17. Nakamura H, Mitani T, Murakami T, et al. Stage III, IV hepatocellular carcinoma patients surviving more than five years after transcatheter chemoembollzation. Jpn J Cancer Chemother. 1992;19:1756-1758.
18. Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology. 1989;10:98-102.
19. Takenaka K, Yoshida K, Nishizaki T, et al. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg. 1995;169:400-405.